Mark Hunter

Mark Hunter is a visionary sales executive with 25 years of experience in biopharmaceuticals, medical devices, and healthcare technology. Currently the Executive Business Director at Eli Lilly and Company, Mark leads a team focused on the Immunology GI franchise. Prior roles include President of Tremar Consulting, Inc., and various leadership positions at Astra Merck, Centocor, and Novo Nordisk A/S, where they consistently achieved multimillion-dollar sales growth. Mark's strategic thinking and relationship-building skills have significantly impacted sales across multiple healthcare sectors. They are pursuing a Bachelor of Business Administration at Iowa State University.